176 related articles for article (PubMed ID: 30414170)
21. Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients.
D'Amico F; Granata M; Skarmoutsou E; Trovato C; Lovero G; Gangemi P; Longo V; Pettinato M; Mazzarino MC
Inflamm Res; 2018 Jul; 67(7):609-616. PubMed ID: 29605872
[TBL] [Abstract][Full Text] [Related]
22. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis.
Ghavami S; Chitayat S; Hashemi M; Eshraghi M; Chazin WJ; Halayko AJ; Kerkhoff C
Eur J Pharmacol; 2009 Dec; 625(1-3):73-83. PubMed ID: 19835859
[TBL] [Abstract][Full Text] [Related]
23. Presence of S100A8/Gr1-Positive Myeloid-Derived Suppressor Cells in Primary Tumors and Visceral Organs Invaded by Breast Carcinoma Cells.
Tanriover G; Eyinc MB; Aliyev E; Dilmac S; Erin N
Clin Breast Cancer; 2018 Oct; 18(5):e1067-e1076. PubMed ID: 29804651
[TBL] [Abstract][Full Text] [Related]
24. Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9.
Hsu YL; Hung JY; Tsai EM; Wu CY; Ho YW; Jian SF; Yen MC; Chang WA; Hou MF; Kuo PL
Oncol Rep; 2015 Dec; 34(6):2889-900. PubMed ID: 26397389
[TBL] [Abstract][Full Text] [Related]
25. S100 Soil Sensor Receptors and Molecular Targeting Therapy Against Them in Cancer Metastasis.
Tomonobu N; Kinoshita R; Sakaguchi M
Transl Oncol; 2020 Apr; 13(4):100753. PubMed ID: 32193075
[TBL] [Abstract][Full Text] [Related]
26. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis.
Ryckman C; McColl SR; Vandal K; de Médicis R; Lussier A; Poubelle PE; Tessier PA
Arthritis Rheum; 2003 Aug; 48(8):2310-20. PubMed ID: 12905486
[TBL] [Abstract][Full Text] [Related]
27. Association between serum levels of the proinflammatory protein S100A8/A9 and clinical and structural characteristics of patients with established knee, hip, and hand osteoarthritis.
Mahler EA; Zweers MC; van Lent PL; Blom AB; van den Hoogen FH; van den Berg WB; Roth J; Vogl T; Bijlsma JW; van den Ende CH; den Broeder AA
Scand J Rheumatol; 2015; 44(1):56-60. PubMed ID: 25179566
[TBL] [Abstract][Full Text] [Related]
28. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis.
Gopal R; Monin L; Torres D; Slight S; Mehra S; McKenna KC; Fallert Junecko BA; Reinhart TA; Kolls J; Báez-Saldaña R; Cruz-Lagunas A; Rodríguez-Reyna TS; Kumar NP; Tessier P; Roth J; Selman M; Becerril-Villanueva E; Baquera-Heredia J; Cumming B; Kasprowicz VO; Steyn AJ; Babu S; Kaushal D; Zúñiga J; Vogl T; Rangel-Moreno J; Khader SA
Am J Respir Crit Care Med; 2013 Nov; 188(9):1137-46. PubMed ID: 24047412
[TBL] [Abstract][Full Text] [Related]
29. S100A8 and S100A9 in inflammation and cancer.
Gebhardt C; Németh J; Angel P; Hess J
Biochem Pharmacol; 2006 Nov; 72(11):1622-31. PubMed ID: 16846592
[TBL] [Abstract][Full Text] [Related]
30. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
[TBL] [Abstract][Full Text] [Related]
31. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
McNeill E; Hogg N
Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
[TBL] [Abstract][Full Text] [Related]
32. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
[TBL] [Abstract][Full Text] [Related]
33. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.
Sinha P; Okoro C; Foell D; Freeze HH; Ostrand-Rosenberg S; Srikrishna G
J Immunol; 2008 Oct; 181(7):4666-75. PubMed ID: 18802069
[TBL] [Abstract][Full Text] [Related]
34. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins.
Wang L; Chang EW; Wong SC; Ong SM; Chong DQ; Ling KL
J Immunol; 2013 Jan; 190(2):794-804. PubMed ID: 23248262
[TBL] [Abstract][Full Text] [Related]
35. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2.
Ghavami S; Kerkhoff C; Chazin WJ; Kadkhoda K; Xiao W; Zuse A; Hashemi M; Eshraghi M; Schulze-Osthoff K; Klonisch T; Los M
Biochim Biophys Acta; 2008 Feb; 1783(2):297-311. PubMed ID: 18060880
[TBL] [Abstract][Full Text] [Related]
36. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
[TBL] [Abstract][Full Text] [Related]
37. Calprotectin and the Initiation and Progression of Head and Neck Cancer.
Argyris PP; Slama ZM; Ross KF; Khammanivong A; Herzberg MC
J Dent Res; 2018 Jun; 97(6):674-682. PubMed ID: 29443623
[TBL] [Abstract][Full Text] [Related]
38. S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNFα.
Shi S; Yi JL
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3925-3935. PubMed ID: 29949169
[TBL] [Abstract][Full Text] [Related]
39. S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell line-1 cells.
Eue I; König S; Pior J; Sorg C
Int Immunol; 2002 Mar; 14(3):287-97. PubMed ID: 11867565
[TBL] [Abstract][Full Text] [Related]
40. S100A8/A9: From basic science to clinical application.
Pruenster M; Vogl T; Roth J; Sperandio M
Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
